Trial Profile
Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Aspirin; Clopidogrel; Ticagrelor; Warfarin
- Indications Coronary thrombosis; Embolism and thrombosis
- Focus Adverse reactions
- 09 Jan 2015 New trial record